Novel biomarkers of inflammation in heart failure with preserved ejection fraction: analysis from a large prospective cohort study
Abstract Background Heart failure with preserved ejection fraction (HFpEF) is a syndrome with a heterogeneous cluster of causes, including non-resolving inflammation, endothelial dysfunction, and multi-organ defects. The present study’s objective was to identify novel predictors of HFpEF. Methods Th...
Main Authors: | Nicholas W. Carris, Rahul Mhaskar, Emily Coughlin, Easton Bracey, Srinivas M. Tipparaju, Ganesh V. Halade |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-022-02656-z |
Similar Items
-
Heart Failure Syndrome With Preserved Ejection Fraction Is a Metabolic Cluster of Non-resolving Inflammation in Obesity
by: Bochra Tourki, et al.
Published: (2021-08-01) -
Inflammation as a therapeutic target in heart failure with preserved ejection fraction
by: Zhen Hui Peh, et al.
Published: (2023-06-01) -
Role of interleukins in heart failure with reduced ejection fraction
by: Oliwia Anna Segiet, et al.
Published: (2019-11-01) -
Role of epicardial adipose tissue in the pathogenesis of chronic inflammation in heart failure with preserved ejection fraction
by: O. N. Dzhioeva, et al.
Published: (2024-04-01) -
Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
by: Yook Chin Chia, et al.
Published: (2021-06-01)